| 2011 |
PACSIN2 F-BAR domain directly interacts with caveolin-1, sculpts caveolar plasma membrane invaginations, and recruits dynamin-2 for caveola fission; knockdown of PACSIN2 causes abnormal caveolin-1-associated plasma membrane morphology and decreased dynamin-2 recruitment. |
Direct binding assay (F-BAR domain–caveolin-1 interaction), membrane tubulation assay, siRNA knockdown with morphological readout |
Journal of cell science |
High |
21610094
|
| 2011 |
PACSIN2 associates with the C-terminal hypervariable domain of Rac1 at intracellular tubular structures and early endosomes; loss of PACSIN2 increases Rac1-GTP levels and promotes cell spreading and migration, while ectopic PACSIN2 reduces Rac1-GTP in a manner dependent on the PACSIN2–Rac1 interaction, PACSIN2 membrane-tubulating capacity, and dynamin. |
Co-immunoprecipitation, siRNA knockdown, wound-healing migration assay, Rac1-GTP pull-down, live-cell imaging |
Journal of cell science |
High |
21693584
|
| 2000 |
Xenopus PACSIN2 (X-PACSIN2) binds the cytoplasmic domain of ADAM13 via SH3-domain interactions in vitro and colocalizes with ADAM13 in membrane ruffles and cytoplasmic vesicles; PACSIN2 overexpression rescues ADAM13-induced developmental defects, while the truncated ΔSH3 form increases ADAM13 activity, indicating PACSIN2 negatively regulates ADAM13 function via its SH3 domain. |
Pull-down assay, co-localization in XTC cells, developmental rescue experiment, truncation mutant analysis |
Developmental biology |
Medium |
11076687
|
| 2014 |
The PACSIN2 F-BAR domain directly binds actin filaments using the same concave surface employed for membrane binding; this interaction is specific to pacsin2 among tested BAR/F-BAR proteins (endophilin, CIP4, FCHO2 did not associate with actin). |
In vitro actin co-sedimentation, structural analysis (cryo-EM/crystallography implied), mutagenesis of membrane-binding surface |
EMBO reports |
High |
25216944
|
| 2015 |
Filamin A (FlnA) binds the tip of the PACSIN2 F-BAR domain (requiring FlnA immunoglobulin-like repeat 20) and enhances PACSIN2 F-BAR domain membrane tubulation in vitro; the FlnA–PACSIN2 interaction regulates PACSIN2 localization and demarcation membrane system (DMS) formation in megakaryocytes, and Flna-null platelets show dispersed PACSIN2 foci and poorly defined DMS. |
Co-immunoprecipitation in human platelets, in vitro membrane tubulation assay, Flna-null mouse model, fluorescence microscopy |
Blood |
High |
25838348
|
| 2015 |
Protein kinase C (PKC) phosphorylates PACSIN2 at serine 313, reducing its membrane-binding and tubulation capacities; phosphorylation decreases caveolar tracking duration at the plasma membrane and correlates with increased dynamin-2 recruitment and activity, triggering caveolae removal. EHD2 expression restores caveolar stability in PACSIN2-depleted or phospho-mimetic S313E cells. |
Site-directed mutagenesis (S313E phospho-mimetic), live-cell caveolar tracking, PKC pharmacological activation, RNAi depletion, in vitro membrane binding assay |
Journal of cell science |
High |
26092940
|
| 2016 |
PACSIN2 concentrates at focal adherens junctions (FAJs) experiencing actomyosin tension, recruited via its F-BAR domain to the trailing end of fast-moving FAJs; PACSIN2 inhibits internalization of VE-cadherin from FAJ trailing ends, and loss of PACSIN2 impairs endothelial monolayer integrity. |
siRNA knockdown, photoconversion and FRAP microscopy, super-resolution microscopy, live-cell imaging, F-BAR domain mutant analysis |
Nature communications |
High |
27417273
|
| 2016 |
TcdA (C. difficile toxin A) undergoes PACSIN2-dependent, dynamin-dependent but clathrin- and caveolae-independent endocytosis; TcdA colocalizes with PACSIN2-positive structures during entry, and RNAi knockdown of PACSIN2 inhibits TcdA uptake and downstream cytopathic effects. |
RNAi knockdown, pharmacological inhibition, confocal microscopy with fluorescently labeled toxin |
PLoS pathogens |
Medium |
27942025
|
| 2018 |
HIV-1 p6 recruits PACSIN2 into virus-like particles independently of TSG101/ALIX; HIV-1 spreading in T cells and PBMCs is severely impaired upon PACSIN2 depletion and can be restored by wild-type PACSIN2 but not by an SH3-domain mutant unable to interact with WASP/N-WASP, indicating PACSIN2 promotes HIV-1 cell-to-cell spread by connecting Gag to the actin cytoskeleton via its SH3 domain. |
VLP incorporation assay, siRNA knockdown, spreading assay, SH3 domain mutant rescue experiment |
Proceedings of the National Academy of Sciences of the United States of America |
High |
29891700
|
| 2019 |
PACSIN2 localizes to L. monocytogenes protrusions and promotes protrusion engulfment during bacterial cell-to-cell spread; RNAi knockdown of PACSIN2 reduces spread efficiency. |
RNAi screen, fluorescence microscopy, bacterial spread assay |
Molecular biology of the cell |
Medium |
31242077
|
| 2019 |
PACSIN2 promotes apical endocytosis in intestinal epithelial cells; PACSIN2 KO mice show reduced microvillar numbers and membrane-lifting defects at brush borders, with loss of dynamin-2 from microvillar rootlets; inhibition of endocytosis phenocopies PACSIN2 loss, placing PACSIN2-dependent endocytic scission upstream of microvillar membrane morphology maintenance. |
PACSIN2 KO mouse, electron microscopy, live-cell endocytosis assay, dynamin2 localization by immunofluorescence |
Molecular biology of the cell |
High |
31390291
|
| 2020 |
PACSIN2 interacts with HCV NS5A via the NS5A domain I and the PACSIN2 F-BAR region; NS5A prevents PKCα from binding PACSIN2, reducing phosphorylation of PACSIN2 at S313 and enhancing NS5A–PACSIN2 interaction; PACSIN2 is required for HCV assembly (not entry or replication) and promotes NS5A–core protein interaction and lipid droplet formation via ERK1/2. |
Co-immunoprecipitation, pulldown assay, immunofluorescence, siRNA knockdown, S313A mutagenesis, viral infectivity assay |
Journal of virology |
High |
31801866
|
| 2021 |
PACSIN2 recruits trafficking regulators EHD4 and MICAL-L1 to the rear end of asymmetric adherens junctions to form a recycling endosome-like tubular structure; this PACSIN2/EHD4/MICAL-L1 complex controls local VE-cadherin trafficking and coordinates polarized endothelial migration and angiogenic sprouting. |
Co-immunoprecipitation, live-cell imaging, siRNA knockdown, in vivo zebrafish angiogenesis assay |
Nature communications |
High |
33972531
|
| 2017 |
PACSIN2 colocalizes and physically interacts with nephrin in podocytes; PACSIN2 overexpression increases both nephrin endocytosis and recycling; rabenosyn-5 is identified as a novel PACSIN2 interactor that enhances the PACSIN2–nephrin association; palmitate (elevated in diabetes) further enhances this association. |
Co-immunoprecipitation, co-localization microscopy, overexpression endocytosis assay, pull-down |
FASEB journal |
Medium |
28550045
|
| 2012 |
PACSIN2 loss increases plasma membrane expression of EGFR in resting cells and enhances EGF-induced EGFR phosphorylation, Erk and Akt activation, and cell proliferation; internalized EGF and activated EGFR translocate to PACSIN2-positive endosomes, identifying PACSIN2 as a regulator of EGFR surface levels and downstream signaling. |
siRNA knockdown, surface EGFR quantification, phospho-immunoblotting, proliferation assay, confocal co-localization |
The Journal of biological chemistry |
Medium |
23129763
|
| 2008 |
Xenopus PACSIN2 localizes to the plasma membrane via its coiled-coil domain; overexpression inhibits gastrulation, fibronectin fibrillogenesis, and ectodermal cell spreading on fibronectin; PACSIN2 overexpression prevents integrin β1 localization to focal adhesions and filamin localization to stress fibers in XTC cells, indicating PACSIN2 regulates activated α5β1 integrin and cytoskeletal organization during cell migration. |
Overexpression and truncation mutant analysis in Xenopus embryos, immunofluorescence, cell spreading assay on fibronectin, mitochondria-anchoring sequestration experiment |
Developmental biology |
Medium |
18495106
|
| 2022 |
PACSIN2 acts as a scaffold in CML cells: it binds Cobll1 and separately binds and inhibits SH3BP1 (a Rac1 pathway activator); Cobll1 preferentially competes with SH3BP1 for PACSIN2 binding, releasing SH3BP1 to activate Rac1 signaling and suppress TKI-induced apoptosis, leading to drug resistance. |
Co-immunoprecipitation, competitive binding assay, siRNA knockdown, apoptosis assay in K562 cells |
Cancer medicine |
Medium |
35352878
|
| 2022 |
Super-resolution microscopy shows that PACSIN2 and EHD2 both localize at caveolin-1-positive caveolae, with PACSIN2 F-BAR domain positioned closer to the plasma membrane than EHD2 and caveolin-1, suggesting PACSIN2 connects caveolae to the plasma membrane; PACSIN2 and EHD2 are present predominantly at typically sized (full-volume) caveolae. |
Single-molecule localization super-resolution (3D-STORM/PALM), spatial proximity clustering analysis |
PloS one |
Medium |
35834519
|
| 2023 |
PACSIN2 inhibits autophagy, putatively by interacting with LC3-II via a LIR motif to inhibit autophagosome formation; knockdown of PACSIN2 modulates mercaptopurine-induced cytotoxicity in intestinal cells; PACSIN2 modulates cellular TPMT activity via mechanisms distinct from its autophagy regulation. |
siRNA knockdown, autophagy flux assay, co-immunoprecipitation (PACSIN2–LC3-II), LIR motif analysis, cytotoxicity assay |
Life science alliance |
Medium |
36596605
|
| 2023 |
PACSIN2 phosphorylation at S313 is increased in diabetic kidney disease glomeruli; pS313-PACSIN2 decreases N-WASP degradation; N-WASP inhibition reciprocally triggers PACSIN2 S313 phosphorylation; pS313-PACSIN2 regulates actin cytoskeleton rearrangement in podocytes, and the dynamic phosphorylation cycle is required for podocyte morphology maintenance. |
Phospho-specific antibody staining in rat DKD glomeruli, pharmacological N-WASP inhibition, phospho-mimetic and phospho-dead PACSIN2 mutants, actin cytoskeleton imaging |
Cells |
Medium |
37296607
|
| 2023 |
PACSIN2 negatively regulates platelet integrin β1 hemostatic function through its interaction with filamin A; Pacsin2-/- mice display thrombocytopenia, prolonged bleeding, unstable thrombi, and hyperactive integrin β1; genetic deletion of integrin β1 in Pacsin2-/- mice normalizes platelet count, hemostasis, and thrombus formation, placing PACSIN2 upstream of integrin β1 activation. |
Pacsin2 KO mouse, integrin β1 KO epistasis, ferric chloride and laser injury thrombosis models, spreading assay on GFOGER, active integrin β1 antibody (9EG7) staining, FlnA-binding peptide pull-down |
Journal of thrombosis and haemostasis |
High |
37678551
|
| 2022 |
In zebrafish larvae, pacsin2 is enriched at the apical pole of renal proximal tubule cells at endocytic structures; loss of pacsin2 reduces endocytosis in the proximal tubule and decreases abundance of megalin and endocytic organelles. |
Pacsin2 morpholino knockdown in zebrafish, fluorescence microscopy, endocytosis assay, megalin immunostaining |
Biology open |
Medium |
35616009
|
| 2026 |
In hippocampal CA1 neurons, chronic stress upregulates PACSIN2; PACSIN2 physically interacts with dynamin and cooperatively modulates postsynaptic GluA1 AMPA receptor expression; selective knockdown of PACSIN2 in dCA1 enhances synaptic transmission and ameliorates depression-like behaviors in rats. |
Co-immunoprecipitation (PACSIN2–dynamin), viral-vector-mediated knockdown in dCA1, electrophysiology, behavioral assays |
Acta pharmacologica Sinica |
Medium |
42098399
|
| 2012 |
PACSIN2 knockdown in human leukemia cells (NALM6) results in significantly lower TPMT activity, and a PACSIN2 SNP (rs2413739) is associated with altered TPMT activity in patients; protein-level correlation between PACSIN2 and TPMT was detected in PBMCs. |
siRNA knockdown with TPMT activity assay, genome-wide association in HapMap cell lines, patient cohort validation |
Human molecular genetics |
Medium |
22846425
|